QuidelOrtho
QDEL
$38.91
Share price
1.12%
Change (1 day)
-28.22%
Change (1 year)
Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.
QuidelOrtho (QDEL) - Total debt
Total debt on the balance sheet as of December 2024 : C$3.71 Billion
According to QuidelOrtho's latest financial reports the company's total debt is C$3.71 Billion. A company’s total debt is the sum of all current and non-current debts.
QuidelOrtho - Total debt on balance sheet (from 1996 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | C$3.84 B | 10.98% |
| 2023-12-31 | C$3.46 B | -10.32% |
| 2022-12-31 | C$3.86 B | 2077.71% |
| 2021-12-31 | C$0.17 B | 28.32% |
| 2020-12-31 | C$0.13 B | -5.67% |
| 2019-12-31 | C$0.14 B | 0.1% |
| 2018-12-31 | C$0.14 B | -70.68% |
| 2017-12-31 | C$0.49 B | 157.61% |
| 2016-12-31 | C$0.19 B | -5.47% |
| 2015-12-31 | C$0.20 B | 23.57% |
| 2014-12-31 | C$0.16 B | 2701.96% |
| 2013-12-31 | C$5.92 M | -45.56% |
| 2012-12-31 | C$10.88 M | -78.5% |
| 2011-12-31 | C$50.63 M | -36.73% |
| 2010-12-31 | C$80.02 M | 1024.86% |
| 2009-12-31 | C$7.11 M | -16.41% |
| 2008-12-31 | C$8.51 M | 9.87% |
| 2007-12-31 | C$7.74 M | -21.17% |
| 2006-12-31 | C$9.82 M | -42.63% |
| 2005-12-31 | C$17.12 M | 47.35% |
| 2004-12-31 | C$11.62 M | -12.12% |
| 2003-12-31 | C$13.22 M | -21.37% |
| 2002-12-31 | C$16.82 M | -23.09% |
| 2001-12-31 | C$21.86 M | 1.38% |
| 2000-12-31 | C$21.57 M | |
| 1999-03-31 | C$4.52 M | -0.26% |
| 1998-03-31 | C$4.53 M | -3.54% |
| 1997-03-31 | C$4.7 M | -24.52% |
| 1996-03-31 | C$6.23 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 | C$42.88 M | -98.85% | 🇺🇸 USA |
 | C$25.98 B | 599.56% | 🇺🇸 USA |
 | C$43.32 B | 1,066.37% | 🇺🇸 USA |
 | C$20.23 M | -99.46% | 🇺🇸 USA |
 | C$23.75 B | 539.44% | 🇺🇸 USA |
 | C$6.24 B | 68.19% | 🇺🇸 USA |